Xiao Bo Lu

Xiao Bo Lu

Director/Board Member at
Qingdao Raisecare Biotechnology Co., Ltd.
53 year
Health Technology
Consumer Services
Finance

Profile

Xiao Bo Lu is currently a Non-Executive Director at Ambio Pharmaceuticals since 2021, a Director at Qingdao Raisecare Biotechnology Co., Ltd. since 2020, and a Partner at Hongshan.
Previously, he held positions as a Non-Independent Director at Beijing Konruns Pharmaceutical Co., Ltd. from 2014 to 2022, a Director at Innovita Biological Technology Co., Ltd. from 2019 to 2023, a Director at Transcenta Holding Ltd., a Director at Chengdu Bright Eye Hospital Co., Ltd. from 2017 to 2022, and a Director at Qingdao Baheal Medical, Inc. He obtained an MBA from Tsinghua University in 2010 and another MBA from Tsinghua University in 2019.
He also holds an undergraduate degree from Zhejiang University, which he received in 1995.

Xiao Bo Lu active positions

CompaniesPositionStart
Private Equity Investor -
Director/Board Member 12/04/2021
Director/Board Member 16/10/2020

Former positions of Xiao Bo Lu

CompaniesPositionEnd
INNOVITA BIOLOGICAL TECHNOLOGY CO., LTD. Director/Board Member 24/02/2023
BRIGHT EYE HOSPITAL GROUP CO., LTD. Director/Board Member 10/10/2022
BEIJING KONRUNS PHARMACEUTICAL CO.,LTD. Director/Board Member 12/04/2022
QINGDAO BAHEAL MEDICAL INC. Director/Board Member -
TRANSCENTA HOLDING LIMITED Director/Board Member -
See the detail of Xiao Bo Lu's experience

Training of Xiao Bo Lu

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

Connections

89

1st degree connections

10

1st degree companies

Male

Female

Members of the board

Executives

Linked companies

Private companies10

Consumer Services

Consumer Services

Finance

Retail Trade

Health Technology

Health Technology

Health Services

Health Technology

Commercial Services

Health Technology

-40%: Exceptional extension
d
:
:
SEIZE THE OFFER!